Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what assessment his Department has made of the adequacy of levels of research and development funding for sickle cell disorder.

UK Research and Innovation (UKRI) delivers a substantial portfolio of researcher-led projects and strategic investments, including research into sickle cell disease, for which UKRI had expenditure of approximately £0.2 million in 2023-24. UKRI also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

The Department of Health and Social Care funds research through the National Institute for Health and Care Research (NIHR). Over the past five years, the NIHR have awarded over £6 million for research related to sickle cell disease.